NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/02/2026
Voltar para busca
Dado oficial do USPTO
BAP PHARMA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BAP PHARMA
ST13
US500000098721885Classe
35, 39, 42
Pedido
98721885
Registro
8123138
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
29
Atualização mais recente
04/02/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 39, 42
Data de depósito
28/08/2024
Data de registro
03/02/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/02/2026
Última transação
04/02/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
24
Localização do titular
Buckinghamshire, GB
Examinador
DONEGAN,DANIEL P
Unidade examinadora
L40
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
BAP Pharma Limited
Representantes
Alison M. Caless Cantor Colburn LLP
Classificação técnica
Classes Nice
Classe 35Classe 39Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Business advisory services; business advisory services relating to supply chain management and the sourcing and procurement of goods and services; business advisory services relating to the manufacturemarketing and sale of pharmaceutical products; business advisory services relating to the operation of clinical trials; business advisory and support services in the nature of consulting concerning marketing authorisations and approvals for pharmaceutical products; business advisory services relating to the provision of bespoke medicines access programs; providing outsourcing services for the procurement and business management of randomisation lists in clinical trialsfor business and commercial purposes; business consultancy services; distributorship services in the field of pharmaceutical products and medical and scientific equipment for use in clinical trials.
Classe 39
Storage and transportation services for pharmaceutical products; packaging services for pharmaceutical products; packaging of pharmaceutical products; re-packaging services for pharmaceutical products; re-packaging of pharmaceutical products; product labelling services for the merchandise of others; cold chain storage and transportation services for pharmaceutical products; cold chain storage and transportation of pharmaceutical products; cold chain storage and transportation of medical and scientific equipment
Classe 42
Conducting clinical trials for others in the field of pharmaceutical products; new product design services; designing and planning clinical trials; packaging design services; design of medical and pharmaceutical product information booklets and leaflets; quality control services for others; quality management services in the nature of quality control services for others; quality management services in the nature of inspection of imported medicinal products for quality control purposes; informationadvisory and consultancy services relating to the aforesaid.
Publicações
Histórico de despachos e eventos da marca no USPTO.
29 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/02/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
16/12/2025
PUBO
PUBLISHED FOR OPPOSITION
16/12/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/12/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/11/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
19/11/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/11/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
19/11/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/11/2025
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/10/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
23/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/09/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
02/09/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/09/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
02/09/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/06/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/06/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/06/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/03/2025
GNRT
NON-FINAL ACTION E-MAILED
05/03/2025
CNRT
NON-FINAL ACTION WRITTEN
05/03/2025
DOCK
ASSIGNED TO EXAMINER
04/03/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
17/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/10/2024
NWAP
NEW APPLICATION ENTERED
28/08/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BAP PHARMA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.